Precise DAPT

Medical

Only for iPhone

Free · Designed for iPhone. Not verified for macOS.

iPhone

The PRECISE-DAPT score calculator provides the percentage probability of major bleeding at twelve months in patients with coronary artery disease treated with dual antiplatelet therapy after coronary stenting. This tool is designed to support clinicians decision making for dual antiplatelet therapy duration after coronary stenting. This calculator specifically designed for mobile devices, provides a rapid and intuitive assessment of patients' bleeding risk. Additional features include: – PRECISE-DAPT score calculation – Estimate of bleeding risk at 12-months for TIMI major and TIMI major or minor bleeding – Bleeding risk status according to the original score categories – Reporting system including all relevant information regarding the antiplatelet therapy selection and stenting procedure – An advanced e-mail reporting system to share information with the patient or other clinicians The PRECISE-DAPT score calculator includes 5 predictive risk factors to calculate the probability of major bleeding: Age Creatinin Clearance Haemoglobin levels White blood cell count History of previous spontaneous bleeding The score has been developed from a collaborative dataset including 14,963 patients from 8 randomized clinical trials, enrolled in more than 130 clinical sites and 12 countries worldwide. The PRECISE-DAPT Risk Score has been externally validated in two independent datasets. The PRECISE-DAPT Score and all related materials are for exclusive use of health care professionals and is intended as a supportive risk assessment tool which should never replace clinical judgment, physician–patient relationship or medical advice. Treatment risks and benefits should always be considered in the context of a comprehensive professional clinical assessment, taking into account all available data and treatment options. Physicians and other healthcare providers should always exercise their own clinical judgment for any given situation.

Ratings & Reviews

  • This app has not received enough ratings or reviews to display an overview.

This update from Apple will improve the functionality of this app. No new features are included. Minor bugfixes

Version 1.2

The developer, Alma Digit Srl, has not provided details about its privacy practices and handling of data to Apple. For more information, see the developer’s privacy policy .

  • No Details Provided

    The developer will be required to provide privacy details when they submit their next app update.

    Accessibility

    The developer has not yet indicated which accessibility features this app supports. Learn More

    Information

    Size
    • 57.8 MB
    Category
    • Medical
    Compatibility
    Requires iOS 8.0 or later.
    • iPhone
      Requires iOS 8.0 or later.
    • iPod touch
      Requires iOS 8.0 or later.
    • Mac
      Requires macOS 11.0 or later and a Mac with Apple M1 chip or later.
    • Apple Vision
      Requires visionOS 1.0 or later.
    Languages
    • English
    Age Rating
    16+
    • 16+
    • Learn More
    • Frequent
      Medical Treatment Information

      Contains
      Unrestricted Web Access
    Provider
    Alma Digit srl
    • Alma Digit srl has identified itself as a trader for this app and confirmed that this product or service complies with European Union law.
    • DUNS Number
      437945811
    • Address
      Contrada Di Dio 1
      98166 Messina Messina
      Italy
    • Phone Number
      +39 3471234340
    • Email
      gi.lucentini@gmail.com
    Copyright
    • © 2017 PRECISE-DAPT Executive Committee. All Rights Reserved.
  • Privacy Policy

    • You Might Also Like